KLIFO is a drug development consultancy and full-service Clinical Trial Supply with significant experience in partnering with pharmaceutical and biotech companies. We enable our partners to maximise opportunity, mitigate risks, drive innovation and achieve efficient project advancement. We offer end to end solutions across all drug development areas, including strategic project management, regulatory affairs, clinical development, clinical trial supply, quality assurance (QA), Chemistry Manufacturing and Controls (CMC) development, non-clinical development and pharmacovigilance in relation to the development of pharmaceutical products. We provide strategic advice as well as operational support in all these areas, and we partner with clients on portfolio strategies, project development strategies and project execution. KLIFO has offices in Denmark and Sweden and employs more than 130 highly skilled experts.
Looking for a particular KLIFO employee's phone or email?
KLIFO Questions
The KLIFO annual revenue was $18.1 million in 2026.
Rene Pedersen is the CEO of KLIFO.
117 people are employed at KLIFO.
KLIFO is based in Glostrup, Capital Region.
The NAICS codes for KLIFO are [3254, 325, 32541, 32].
The SIC codes for KLIFO are [283, 28].
Top KLIFO Employees
-
Rene Pedersen
Chief Executive Officer at KLIFO
Copenhagen, DK25+ -
Rasmus Nelund
Chief Executive Officer at KLIFO
Copenhagen, DK1 -
1
-
Rasmus Rabøl
EVP and Head of Advisory at KLIFO
Copenhagen, DK11 -
55+
-
Estera Kuczer
Business Development Director, CTS at KLIFO
United Kingdom12 -
Henriette Pedersen
Senior Director at KLIFO
Glostrup, DK11 -
22
-
Christina Vinum
Executive Vice President at KLIFO
Copenhagen, DK11
Related Companies
